(Q34108988)

31 July 2017

1 reference

title

Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis (English)

1 reference

antiphospholipid syndrome

31 July 2017

main subject

1 reference

Amigo MC

1

1 reference

31 July 2017

García-Torres R

series ordinal

2

1 reference

31 July 2017

publication date

1 June 2000

1 reference

Current Rheumatology Reports

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

262-270

1 reference

Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients

31 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-000-0089-4

Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-000-0089-4

A HITHERTO UNDESCRIBED FORM OF VALVULAR AND MURAL ENDOCARDITIS

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-000-0089-4

Renal infarction in a severely hypertensive patient with lupus erythematosus and antiphospholipid antibodies

21 January 2018

1 reference

12 December 2020

Regulatory mechanisms of transmembrane phospholipid distributions and pathophysiological implications of transbilayer lipid scrambling

1 reference

12 December 2020

Abnormally high level of C4b binding protein and deficiency of free fraction of protein S in a patient with systemic lupus erythematosus and recurrent thromboses

1 reference

12 December 2020

Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I

1 reference

12 December 2020

Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves

1 reference

12 December 2020

Vasculopathy associated with the antiphospholipid antibody syndrome

1 reference

12 December 2020

Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings

1 reference

12 December 2020

Lupus nephritis. Clinical course as related to morphologic forms and their transitions

1 reference

12 December 2020

Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant

1 reference

12 December 2020

Fibromuscular dysplasia of the renal arteries associated with antiphospholipid autoantibodies: two case reports

1 reference

12 December 2020

Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome

1 reference

12 December 2020

Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome

1 reference

12 December 2020

Noninflammatory renal microangiopathy of systemic lupus erythematosus ('lupus vasculitis').

1 reference

12 December 2020

Renal vein thrombosis caused by primary antiphospholipid syndrome

1 reference

12 December 2020

Allograft membranous glomerulonephritis and renal-vein thrombosis in a patient with a lupus anticoagulant factor

1 reference

12 December 2020

Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome

1 reference

12 December 2020

Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis

1 reference

12 December 2020

Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?

1 reference

12 December 2020

Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes

1 reference

12 December 2020

Mechanisms of autoantibody-mediated thrombosis

1 reference

12 December 2020

Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression

1 reference

12 December 2020

Beta2-glycoprotein I as a 'cofactor' for anti-phospholipid reactivity with endothelial cells

1 reference

12 December 2020

Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure

1 reference

12 December 2020

Detection of endothelial cell-reactive immunoglobulin in patients with anti-phospholipid antibodies

1 reference

12 December 2020

A possible role for antiphospholipid antibodies in acquired cardiac valve deformity

1 reference

12 December 2020

Bilateral renal artery occlusion in a patient with primary antiphospholipid antibody syndrome: thrombosis, vasculitis or both?

1 reference

12 December 2020

Primary antiphospholipid syndrome with multiorgan arterial and venous thromboses

1 reference

12 December 2020

Intracardiac thrombus in systemic lupus erythematosus associated with lupus anticoagulant

1 reference

12 December 2020

Inhibitory activity of anti-beta 2-glycoprotein I antibody on factor Va degradation by activated-protein C and its cofactor protein S

1 reference

12 December 2020

Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation

1 reference

12 December 2020

Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant

1 reference

12 December 2020

Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant"

1 reference

12 December 2020

Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis

1 reference

12 December 2020

Brain vascular changes in the case of primary antiphospholipid syndrome

1 reference

12 December 2020

High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome

1 reference

12 December 2020

Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies

1 reference

12 December 2020

Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I

1 reference

12 December 2020

Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thromboses, antiphospholipid antibodies, and the antiphospholipid syndrome

1 reference

12 December 2020

Etiology and management of chronic valve disease in antiphospholipid antibody syndrome and systemic lupus erythematosus

1 reference

12 December 2020

Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment

1 reference

12 December 2020

Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome

1 reference

12 December 2020

Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA.

1 reference

12 December 2020

Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus

1 reference

12 December 2020

Postpartum bilateral renal vein thrombosis in the primary antiphospholipid syndrome

1 reference

12 December 2020

Recurrent renal thrombotic angiopathy after kidney transplantation in two patients with primary antiphospholipid syndrome (PAPS)

1 reference

12 December 2020

The lupus anticoagulant and eicosanoids

1 reference

12 December 2020

Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies.

1 reference

12 December 2020

The anticardiolipin syndrome

1 reference

12 December 2020

Anticardiolipin antibodies and renovascular hypertension

1 reference

12 December 2020

Antiphospholipid arterial vasculopathy

1 reference

12 December 2020

Valvulopathy in primary antiphospholipid syndrome. Prospective echocardiography study

1 reference

12 December 2020

Antiphospholipid antibody syndrome with involvement of a bioprosthetic heart valve.

1 reference

12 December 2020

Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus

1 reference

12 December 2020

Resolution of vegetations with anticoagulation after myocardial infarction in primary antiphospholipid syndrome

1 reference

12 December 2020

The intrarenal vascular lesions associated with primary antiphospholipid syndrome

1 reference

12 December 2020

Renal involvement in primary antiphospholipid syndrome

1 reference

12 December 2020

10.1007/S11926-000-0089-4

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1008184206

0 references

1 reference